BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 30816843)

  • 1. Defining early events of Epstein-Barr virus (EBV) infection in immortalized nasopharyngeal epithelial cells using cell-free EBV infection.
    Pang PS; Liu T; Lin W; Tsang CM; Yip YL; Zhou Y; Guan XY; Chan RC; Tsao SW; Deng W
    J Gen Virol; 2019 Jun; 100(6):999-1012. PubMed ID: 30816843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells.
    Tsang CM; Yip YL; Lo KW; Deng W; To KF; Hau PM; Lau VM; Takada K; Lui VW; Lung ML; Chen H; Zeng M; Middeldorp JM; Cheung AL; Tsao SW
    Proc Natl Acad Sci U S A; 2012 Dec; 109(50):E3473-82. PubMed ID: 23161911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus infection in immortalized nasopharyngeal epithelial cells: regulation of infection and phenotypic characterization.
    Tsang CM; Zhang G; Seto E; Takada K; Deng W; Yip YL; Man C; Hau PM; Chen H; Cao Y; Lo KW; Middeldorp JM; Cheung AL; Tsao SW
    Int J Cancer; 2010 Oct; 127(7):1570-83. PubMed ID: 20091869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EBV infection is associated with histone bivalent switch modifications in squamous epithelial cells.
    Leong MML; Cheung AKL; Dai W; Tsao SW; Tsang CM; Dawson CW; Mun Yee Ko J; Lung ML
    Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14144-14153. PubMed ID: 31235597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneous, restricted patterns of Epstein-Barr virus (EBV) latent gene expression in patients with chronic active EBV infection.
    Yoshioka M; Ishiguro N; Ishiko H; Ma X; Kikuta H; Kobayashi K
    J Gen Virol; 2001 Oct; 82(Pt 10):2385-2392. PubMed ID: 11562532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin.
    Ramayanti O; Juwana H; Verkuijlen SA; Adham M; Pegtel MD; Greijer AE; Middeldorp JM
    Int J Cancer; 2017 Jan; 140(1):149-162. PubMed ID: 27600027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification.
    Shannon-Lowe C; Adland E; Bell AI; Delecluse HJ; Rickinson AB; Rowe M
    J Virol; 2009 Aug; 83(15):7749-60. PubMed ID: 19439479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival.
    Tempera I; De Leo A; Kossenkov AV; Cesaroni M; Song H; Dawany N; Showe L; Lu F; Wikramasinghe P; Lieberman PM
    J Virol; 2016 Jan; 90(1):345-55. PubMed ID: 26468528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BZLF1 controlled by family repeat domain induces lytic cytotoxicity in Epstein-Barr virus-positive tumor cells.
    Wang H; Zhao Y; Zeng L; Tang M; El-Deeb A; Li JJ; Cao Y
    Anticancer Res; 2004; 24(1):67-74. PubMed ID: 15015577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.
    Dheekollu J; Malecka K; Wiedmer A; Delecluse HJ; Chiang AK; Altieri DC; Messick TE; Lieberman PM
    Oncotarget; 2017 Jan; 8(5):7248-7264. PubMed ID: 28077791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.
    Nawandar DM; Ohashi M; Djavadian R; Barlow E; Makielski K; Ali A; Lee D; Lambert PF; Johannsen E; Kenney SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.
    Rac J; Haas F; Schumacher A; Middeldorp JM; Delecluse HJ; Speck RF; Bernasconi M; Nadal D
    PLoS One; 2015; 10(4):e0123645. PubMed ID: 25856387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell Cycle.
    Eichelberg MR; Welch R; Guidry JT; Ali A; Ohashi M; Makielski KR; McChesney K; Van Sciver N; Lambert PF; KeleČ™ S; Kenney SC; Scott RS; Johannsen E
    mBio; 2019 Aug; 10(4):. PubMed ID: 31431547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dominant-negative derivative of EBNA1 represses EBNA1-mediated transforming gene expression during the acute phase of Epstein-Barr virus infection independent of rapid loss of viral genome.
    Kariya Y; Hamatake M; Urano E; Yoshiyama H; Shimizu N; Komano J
    Cancer Sci; 2010 Apr; 101(4):876-81. PubMed ID: 20132216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
    Zhang J; Jia L; Tsang CM; Tsao SW
    Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BZLF1 transcript variants in Epstein-Barr virus-positive epithelial cell lines.
    Needham J; Adamson AL
    Virus Genes; 2019 Dec; 55(6):779-785. PubMed ID: 31552622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive diagnosis of nasopharyngeal carcinoma: nasopharyngeal brushings reveal high Epstein-Barr virus DNA load and carcinoma-specific viral BARF1 mRNA.
    Stevens SJ; Verkuijlen SA; Hariwiyanto B; Harijadi ; Paramita DK; Fachiroh J; Adham M; Tan IB; Haryana SM; Middeldorp JM
    Int J Cancer; 2006 Aug; 119(3):608-14. PubMed ID: 16572427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer.
    Huang J; Chen H; Hutt-Fletcher L; Ambinder RF; Hayward SD
    J Virol; 2003 Dec; 77(24):13267-74. PubMed ID: 14645583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter.
    Zhang Y; Wang H; Liu Y; Wang C; Wang J; Long C; Guo W; Sun X
    Biomed Pharmacother; 2018 Jun; 102():1003-1014. PubMed ID: 29710517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galectin-9 Facilitates Epstein-Barr Virus Latent Infection and Lymphomagenesis in Human B Cells.
    Xu JX; Zhang R; Huang DJ; Tang Y; Ping LQ; Huang BJ; Huang HQ; Busson P; Li J
    Microbiol Spectr; 2023 Feb; 11(1):e0493222. PubMed ID: 36622166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.